NCT05714670View on ClinicalTrials.gov

The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

October 1, 2023

Study Completion Date

August 1, 2024

Conditions
Lupus NephritisSLE Nephritis
Interventions
DRUG

Curcumin Oral Capsule

Curcumin 1000 mg Oral Capsule beside the standard of care

Trial Locations (1)

Unknown

Outpatients Clinic of Pediatric Rheumatology department - Children's Hospital, Ain Shams University, Cairo, Egypt., Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER